-
Global Biopharma Layoffs March 2026
Layoffs
Global Biopharma companies including Merck, Baye, and Novartis announce workforce reductions in March 2026 as part of cost-saving and strategic realignments, impacting research, technology, and leadership roles across their operations.
-
Global Biopharma Layoffs November 2025
Layoffs
This article tracks recent biotech and pharma layoffs, including major workforce cuts at Novo Nordisk, Takeda, GSK, Pharming, and others, as companies restructure operations, streamline pipelines, and refocus resources amid shifting market conditions.
-
Bayer $1.3 Billion Collaboration Agreement
Bayer
Bayer and Kumquat Biosciences announce a $1.3 billion global collaboration to develop and commercialize a KRAS G12D inhibitor, aiming to offer new treatment options for pancreatic, colorectal, and lung cancer patients.
-
-
-
-
-
Bayer's 2024 Financial report
Financial statements
Bayer's 2024 financial report reveals a 2.2% revenue decline, 6,908 job cuts, and ongoing legal battles. With strategic shifts and heavy R&D investment, the company faces challenges and opportunities ahead. Can Bayer turn the tide by 2025?
-
-
天津市|
铁岭县|
永宁县|
仁怀市|
廉江市|
侯马市|
岑溪市|
五寨县|
冕宁县|
正镶白旗|
江川县|
霍邱县|
赫章县|
阿拉善盟|
濮阳县|
白河县|
辽阳市|
新密市|
拉萨市|
嘉荫县|
应城市|
曲靖市|
苏尼特左旗|
青河县|
鄂尔多斯市|
宁津县|
犍为县|
曲松县|
宽甸|
吕梁市|
尉氏县|
衡南县|
荥经县|
治多县|
乌鲁木齐县|
奈曼旗|
霍邱县|
南昌市|
云和县|
溧水县|
高淳县|